Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Wilde deze maand positief beginnen. Als de winst de rest van het jaar doorgroeit, zoals in het eerste half jaar dan zal de winst uitkomen voor 2018 op zo een 75 pence. Hang daar je K/W aan dan weet je wat jij van de koers mag verwachten. Voor mij zelf weet ik het:-)) Fijn weekend trinko
Eerst maar eens door die bubbel van 10 pond heen, en dan hoop ik toch echt binnen een jaar op die 15 pond te komen, ben voorzichtig en blijf aan boord.
Even wat voor moderater Henk. Wanneer worden de berichten over Sopheon eens bijgewerkt. Er zijn alleen maar berichten te lezen tot 2012. Is eigenlijk een heel slechte zaak, wanneer men ambieert een z.g. info baak voor de belegger te zijn.
Ik heb een beetje een gevoel dat we met de koers de verkeerde kant op gaan-:)) maar het jaar is nog lang dus heb er nog heel veel vertrouwen in!
Het lijkt wel als of we slechte cijfers gezien hebben. Wat een raar koersverloop!
Was vorig jaar precies hetzelfde pietje, er zijn altijd mensen die hopen een snelle rit te maken richting de cijfers, als dat dan uit blijft willen ze van hun stukjes af, mooie kansen om bij te kopen!
Doosan Bobcat North America Awards Sopheon Innovation Contract Innovation Market Warms Up to Software-as-a-Service Sopheon, the international provider of software, expertise, and best practices for enterprise innovation management solutions, announces that it has received a contract from Doosan Bobcat North America to deploy its Accolade® software enterprise wide. This award represents additional evidence that the market is beginning to accept the software-as-a-service (SaaS) model for management of innovation processes and decision support. In spite of significant interest in the benefits of SaaS deployments, large organizations have been slow to move their innovation activities into the Cloud. A growing number of recent new client acquisitions by Sopheon, however, have opted for Sopheon’s SaaS solution. One such customer, Doosan Bobcat, whose software implementation went live just last month, selected Sopheon’s Accolade software as the solution of choice to manage the company’s portfolio of projects across a number of corporate groups. Doosan Bobcat purchased a software-as-a-service cloud solution over purchasing licenses in perpetuity and installing the software on premises. “We chose to partner with Sopheon on this initiative as they offered the best solution to help us maximize the performance of a range of critical business processes. Sopheon’s software will enable us to better align our people and investments with our strategic and financial goals.” said Twila Perhus, Director of Global IT PMO. For Further Information Contact: Barry Mence, Chairman Arif Karimjee, CFO Sopheon plc + 44 (0) 1276 919 560 Carl Holmes / Giles Rolls (Corporate Finance) Alice Lane (ECM) finnCap Ltd + 44 (0) 20 7220 0500 About Doosan Bobcat North America Doosan Bobcat North America is the U.S. and Canadian subsidiary of Doosan Bobcat Inc., representing the world-renowned brands of Bobcat® compact equipment, Doosan® portable power products and Geith® attachments. These companies are industry leaders in the engineering, manufacturing, and marketing of compact construction equipment, generators, air compressors, lighting systems, light compaction equipment, and attachments. About Sopheon Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.www.sopheon.com/doosan-bobcat-north-a...
Contract evidences growing SaaS acceptance Accolade solution for Doosan Bobcat North America Sopheon has received a contract from Doosan Bobcat North America to deploy its Accolade software to manage Doosan Bobcat’s portfolio of projects across a number of corporate groups. The implementation went live in August. In its recent interim results announcement, Sopheon noted that it had signed a number of Software-as-a-Service (SaaS) deals and extensions including a major new win. Our estimates already reflect that backdrop. Doosan Bobcat’s decision to go with a SaaS contract is another example of the growing acceptance of the SaaS model within the market for enterprise innovation management solutions. In the results announcement, Sopheon also said that it planned to make specific investment in product, people and processes to further extend Accolade. This will provide impetus to the Group’s focus on expanding its “lifetime value” opportunities across a number of blue chip clients through extending the business application areas addressed by Accolade. It recently released Accolade version 12.1. Sopheon produced a strong performance in the first half of 2018 and the Group retains both good momentum and excellent revenue visibility. We look forward to further updates.
Is geen klein ordertje, anders was er geen bericht. Gr Arie de Beuker
Helaas doet de koers er niet veel op, maar is zeker een mooie nieuwe kans
A growing number of recent new client acquisitions by Sopheon, however, have opted for Sopheon’s SaaS solution
Bobcat is groot in mini big machinery het is een begrip in de bouw over de hele wereld!
Praiser als het grote orders zijn waar ze iemand voor hebben aangetrokken, dan zou de inkomsten voor 2018 wel eens rond de 40 milj $ komen te liggen lijkt mij dat het er steeds zonniger uit begint te zien. Mijn bescheiden mening. En hoop dit jaar ook nog op een overname of merger. Gr trinko
We worden flink gepiepeld. Ik kan niet anders dan denken dat er een partij is die genoeg stukjes heeft om de kleine belegger uit te roken. Bangmakerij, want met de berichten van de afgelopen tijd, kun je een koersdaling gewoon niet rechtvaardigen. Ik blijf dus lekker zitten, koop bij en heb mijn horizon gelegd over vier jaar. Mits alles zo blijft natuurlijk. Geen advies dus, wel een hersenspinsel.
Dat begin ik nu ook te geloven! Waar blijven de institionele beleggers. Zou dit uitstekende happens te Klein zijn voor hun? Effie ik blij ook zitten!
Dit zijn taalfouten door automatische letterinvulling van Apple moet hapje zijn en Effin ik blijf ook zitten
www.youinvest.co.uk/sharesmagazine/20... S ome readers will remember the name Sopheon (SPE:AIM) since we have updated many times on our previous Great Idea from 2 June 2017 at 330p. We actually first flagged the company in August 2016 at 202p. The shares have been on a rampant run, nudging above £10.00 twice this year. We still think there is very decent upside from current levels. Before we explain our reasons, it’s first important to understand what Sopheon does. The Surrey-based software company helps streamline the research and development process for clients and provides product lifecycle management tools. From early roots as a provider of process automation tools, it has emerged as an innovation management solution to complex manufacturers. Sopheon has more than 60,000 users across 50-plus countries worldwide, featuring the likes of NASA, Merck and BASF. Its Accolade platform is used on innovation projects worth an estimated £25bn. Analysts at stockbroker FinnCap calculate a fair value over the next year or so of roughly £13.00, and here’s why we agree. EXPANDING AND MORE PREDICTABLE Sopheon is successfully expanding beyond its traditional industrial engineering-type space. Areas like consumer goods, food and drink, and technology development are proving to be useful new growth areas, while the company is also closing watching insurance, automotive and other industries. Bit by bit Sopheon’s revenues are becoming more predictable. Half year to 30 June 2018 figures reveal recurring revenue grew to $13.7m from $10.5m a year earlier. Recurring revenue has roughly doubled in about three years. Once you factor in contracted maintenance income from multi-year licences, $27.2m of the current full year’s $31m forecast revenue is effectively in the bag, and that’s before the typically busy fourth quarter for new licence sales. FinnCap suggests current earnings expectations are pitched conservatively. That means there is ongoing potential for guidance upgrades, something the company has been able to do multiple times over the past few years. Forecast $0.432 earnings per share (EPS) this year will be less than the $0.472 achieved in 2017 but not something to worry about. It goes back to the conversion last December of loan notes into equity, a one-off event that will not impact the financial performance beyond 2018. FinnCap’s 2019 estimates call for EPS of $0.537 on unbroken revenue growth to $35m. The business had $15.5m net cash at the end of June this year (2017: $6.6m), forecast to rise to $21.4m by the end of 2019. It has also started paying dividends, although this year’s prospective yield is very small at 0.3%. (SF)
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
873,40
-0,07%
EUR/USD
1,0701
+0,04%
FTSE 100
8.103,49
+0,78%
Germany40^
17.947,70
-0,78%
Gold spot
2.324,75
+0,37%
NY-Nasdaq Composite
15.712,75
+0,10%
Stijgers
Dalers